Trial intelligence / Profile preview

Comparing the Effect of Gabapentin and Cinnarizine on Tinnitus

IRCT20221002056073N1Phase 3Completed

Sponsor
Urmia University of Medical Sciences
Start
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin and cinnarizine in tinnitus (2 arms), sponsored by Urmia University of Medical Sciences. Started Oct 2022; status: completed.

02

Drugs

gabapentincinnarizine
03

Conditions

tinnitus

Beyond the preview

Go deeper on IRCT20221002056073N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221002056073N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call